Skip to main content

Table 1 The questions asked to the patients during their initial, pregnancy test day and U/S day visits

From: Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy

1st Visit (ET day)

 AGE

 BMI

 Endometrial Thickness-

 Infertility type

  - 1ry

  -2ry

 Duration of infertility

 Menstrual pattern

  - regular

  - irregular

 Infertility factor

  -anovulation

  -endometriosis

  -male factor

  -tubal factor

  -other

 Type of cycle:

  IVF

  ICSI

  IVF/ ICSI

 Patient choice:

  - Cyclogest

  - Gestone

2nd Visit (Preg. test day)

 -Pregnancy test:

  -ve

   + ve

 -Was the type of progesterone changed?

  YES

  NO

 -Side effects:-

  Perineal irritation

  Rectal itching

  Vaginal bleeding

  Vaginal or rectal leaking or discharge

  Constipation

  Discomfort after administration

  Hematoma formation

  Other

 -Patient’s compliance:

 -Patients satisfaction: 1(least satisfaction), 2, 3, 4, 5 (most satisfaction)

3rd Visit (U/S day, 7 wks. Preg.)

 -Was the type of Progesterone changed?

  YES

  NO

 -Side effects:

  Perineal irritation

  Rectal itching

  Vaginal bleeding

  Vaginal or rectal leaking or discharge

  Constipation

  Discomfort after administration

  Hematoma formation

  Other

 -Patient’s compliance:

 -Patients satisfaction: 1(least satisfaction), 2, 3, 4, 5 (most satisfaction)

 -Pregnancy outcome:

  • Biochemical

  • Clinical